NEW YORK (GenomeWeb) – Trovagene said after the close of the market on Tuesday that its revenues in the first quarter increased 14 percent year over year. 

For the three months ended March 31, the San Diego-based cell-free molecular diagnostics firm recorded $127,000 in total revenues, up from $111,000 in the year-ago quarter, easily beating analysts' average estimate of $80,000. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.